CENTENE CORP
CNCHealthcarecentene.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 27, 2026
Next reportFebruary 4, 2027after close · forecast -1.142 $/share
Revenue
$50.65B
▲ +1.9% vs prior year YoY
Net income
−$71.00M
▲ +98.9% vs prior year YoY
EPS
-0.14$
▲ +99.0% vs prior year YoY
Net margin
-0.1%
▲ +13.2 pp vs prior year YoY
Revenue▲ +1.9%
Margins (% of revenue)GrossOperatingNet
Net income▲ +98.9%
EPS▲ +99.0%
Financial statements
View 10-Q filed October 27, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $40.80B | $46.62B | $48.74B | $49.69B | $49.73B | $49.94B | $53.58B | $50.65B | ▲ +1.9% |
| Gross profit | $3.80B | $5.29B | $3.02B | $3.35B | $2.56B | $5.65B | $4.62B | $3.30B | ▼ -1.3% |
| Operating income | $175.00M | $1.53B | −$458.00M | −$6.95B | −$1.75B | $1.86B | $1.20B | −$307.00M | ▲ +95.6% |
| Net income | $283.00M | $1.31B | −$253.00M | −$6.63B | −$1.10B | $1.54B | $1.09B | −$71.00M | ▲ +98.9% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 2.63 $ | -0.51 $ | -13.50 $ | — | 3.11 $ | 2.19 $ | -0.14 $ | ▲ +99.0% |
| Margins (% of revenue) | |||||||||
| Gross | 9.3 % | 11.3 % | 6.2 % | 6.7 % | 5.1 % | 11.3 % | 8.6 % | 6.5 % | ▼ -0.2 pt |
| Operating | 0.4 % | 3.3 % | -0.9 % | -14.0 % | -3.5 % | 3.7 % | 2.2 % | -0.6 % | ▲ +13.4 pt |
| Net | 0.7 % | 2.8 % | -0.5 % | -13.3 % | -2.2 % | 3.1 % | 2.0 % | -0.1 % | ▲ +13.2 pt |
| Balance sheet | |||||||||
| Assets | $82.44B | $87.04B | $86.39B | $82.09B | $76.75B | $81.17B | $83.01B | $79.28B | ▼ -3.4% |
| Liabilities | $55.94B | $59.02B | $58.89B | $61.03B | $56.69B | $59.65B | $60.35B | $56.97B | ▼ -6.7% |
| Equity | $26.50B | $28.01B | $27.49B | $21.03B | $20.03B | $21.50B | $22.63B | $22.28B | ▲ +5.9% |
| Cash | $14.06B | $14.81B | $14.51B | $17.06B | $17.89B | $21.26B | $24.15B | $20.70B | ▲ +21.4% |
| Capital | |||||||||
| Shares outstanding | 496.04M | 497.60M | 491.13M | 491.52M | 491.77M | 493.80M | 494.00M | 495.07M | ▲ +0.7% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.